Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II metronomic combination therapy trial in children and adolescents with recurrent or progressive neuroblastoma
2011-004593-29Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Oct 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib, cyclophosphamide, etoposide, vinblastine and propranolol in neuroblastoma, sponsored by University of Cologne. Primary endpoint: Event-free survival. Started Oct 2015; status: completed.
02
Drugs
celecoxibcyclophosphamideetoposidevinblastinepropranolol
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on 2011-004593-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004593-29.